Ionis (partnering with Novartis), Amgen, and Silence Therapeutics are developing antisense oligonucleotides targeting Lp(a).

“i know there's three companies that have uh antisense oligonucleotides against uh lpa so you have uh ionis which is partnering with novartis for the for the the trial uh amgen has one uh and there's also another uh sir any company called silence therapeutics that have that have an lpa inhibitor”